(2S,4R)-1-((S)-2-(tert-butyl)-14-(4-(((3-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl)methyl)phenyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-6,9,12-trioxa-3-azatetradecanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide

ID: ALA5283052

Chembl Id: CHEMBL5283052

Max Phase: Preclinical

Molecular Formula: C55H66N10O9S

Molecular Weight: 1043.26

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NCCOCCOCCOCCn2cc(CNc3cccc(Cc4c(C)c5ccc(Oc6ncccn6)cc5oc4=O)c3)nn2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C55H66N10O9S/c1-35-45-16-15-44(73-54-57-17-8-18-58-54)30-48(45)74-53(69)46(35)28-38-9-7-10-41(27-38)59-31-42-32-64(63-62-42)20-22-71-24-26-72-25-23-70-21-19-56-50(55(4,5)6)52(68)65-33-43(66)29-47(65)51(67)61-36(2)39-11-13-40(14-12-39)49-37(3)60-34-75-49/h7-18,27,30,32,34,36,43,47,50,56,59,66H,19-26,28-29,31,33H2,1-6H3,(H,61,67)/t36-,43+,47-,50+/m0/s1

Standard InChI Key:  JBDVDQPOIUKFAX-YAACMXKBSA-N

Alternative Forms

  1. Parent:

    ALA5283052

    ---

Associated Targets(Human)

MAP2K2 Tclin VHL-MAP2K1/MAP2K2 (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1043.26Molecular Weight (Monoisotopic): 1042.4735AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source